EMA board meeting: new clinical trials database 'nearing completion'

At the European Medicines Agency’s (EMA) June management board meeting, members discussed progress in preparations for the agency’s relocation to Amsterdam and other matters related to Brexit, including the impact on implementation of the new EU Clinical Trials Regulation (CTR).

Regulations setting up a new system for registering clinical trials, including a new portal and database, entered into effect in 2014. However, implementation has stalled as development of the tools has taken longer than planned, pushing back the new system by several years.

Discussing progress in the ongoing project, the board said that the release of the portal and database is “nearing completion,” and “in an intensive phase of testing.”